Last reviewed · How we verify
Tehalose 30gr
Tehalose is an excipient used as a stabilizer in pharmaceutical formulations.
Tehalose is an excipient used as a stabilizer in pharmaceutical formulations. Used for Stabilizer in various pharmaceutical formulations.
At a glance
| Generic name | Tehalose 30gr |
|---|---|
| Also known as | Cabellta |
| Sponsor | Bioblast Pharma Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Tehalose is a disaccharide composed of glucose molecules that helps to prevent the degradation of active pharmaceutical ingredients in formulations. It is commonly used in injectable and ophthalmic products.
Approved indications
- Stabilizer in various pharmaceutical formulations
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tehalose 30gr CI brief — competitive landscape report
- Tehalose 30gr updates RSS · CI watch RSS
- Bioblast Pharma Ltd. portfolio CI